Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Liquidia Corporation - Common Stock (NQ:LQDA)

35.03 -1.74 (-4.73%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 955,019
Open 36.61
Bid (Size) 35.02 (100)
Ask (Size) 35.37 (100)
Prev. Close 36.77
Today's Range 35.01 - 37.23
52wk Range 11.26 - 46.67
Shares Outstanding 85,860,949
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Liquidia Stock Up 135% as Insider Sells $1.3 Million in Shares ↗
This biotech innovator in rare disease therapies reported significant insider selling amid a year of robust stock performance. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Dave Stock Soars 150% in a Year as Newly Disclosed $7 Million Buy Signals Confidence in Fintech Upstart ↗
Dave Inc. delivers digital banking and personal finance tools designed to offer alternatives to traditional banking platforms. 
Via The Motley Fool
Topics ETFs

Performance

YTD
+11.6%
+11.6%
1 Month
+4.3%
+4.3%
3 Month
+1.8%
+1.8%
6 Month
+56.0%
+56.0%
1 Year
+135.6%
+135.6%

More News

Read More
Liquidia Corp (NASDAQ:LQDA) Shows High-Growth Momentum and Minervini Trend Alignment ↗
Via Chartmill
News headline image
Liquidia (LQDA) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Liquidia Corp (NASDAQ:LQDA) Reports Q4 2025 Profitability and Revenue Beat Driven by YUTREPIA Launch ↗
Via Chartmill
Liquidia Corp (NASDAQ:LQDA) Identified as High-Growth Momentum Candidate by Minervini Trend Template ↗
Via Chartmill
News headline image
Liquidia Stock Gains Premarket On Q4 Revenue Beat – Investors Are Betting On YUTREPIA Growth ↗
Via Stocktwits
Topics Artificial Intelligence
News headline image
Liquidia Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
Investment Manager Fully Exits Immunome Stock in $37.3 Million Sale, According to Latest SEC Filing ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Investment Manager Sells $5.1 Million Worth of LQDA Stock, According to Recent SEC Filing ↗
Via The Motley Fool
Topics Regulatory Compliance
LIQUIDIA CORP (NASDAQ:LQDA) Emerges as a High-Growth Momentum and Trend Template Candidate ↗
Via Chartmill
News headline image
The Moonshot Medicine: United Therapeutics Surges on Record Earnings and TreSMI Breakthrough
Via Finterra
Topics Earnings Economy Intellectual Property
News headline image
United Therapeutics (UTHR) Deep Dive: Strong Q4 and the ‘Inhalation Evolution’
Via Finterra
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Liquidia Corporation to Report Full Year 2025 Financial Results on March 5, 2026
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
Liquidia to Present Clinical Data Across Its Portfolio at the Pulmonary Vascular Research Institute 2026 Annual Congress
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
Why Liquidia Stock Rocked the Market Today ↗
Via The Motley Fool
News headline image
Liquidia Corporation Announces Preliminary Full-Year 2025 YUTREPIA Net Sales and Corporate Update
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
Liquidia Corporation to Present at 44th Annual J.P. Morgan Healthcare Conference
From Liquidia Technologies, Inc.
Via GlobeNewswire
News headline image
Liquidia Corp (NASDAQ:LQDA) Emerges as a High-Growth Momentum Leader ↗
Via Chartmill
News headline image
One Fund Just Dumped $13 Million in This Offshore Drilling Stock — Here's What Long-Term Investors Should Know ↗
Via The Motley Fool
News headline image
This Small-Cap Consumer Stock Has Landed New Institutional Backing as Shares Surge 60% ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This Fund Leaned Into 2025's Big Biotech Rally with a $9.5 Million Bet on Mineralys ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This Biotech Fund Made a New $40 Million Bet on Liquidia Amid Blockbuster Commercial Drug Launch ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Liquidia Corp (LQDA) Stock: A High-Growth Pick Meeting the Minervini Trend Template ↗
Via Chartmill
News headline image
Henry Schein, Sanmina, Wingstop, Waters And Other Big Stocks Moving Higher On Tuesday ↗
Via Benzinga

Frequently Asked Questions

Is Liquidia Corporation - Common Stock publicly traded?
Yes, Liquidia Corporation - Common Stock is publicly traded.
What exchange does Liquidia Corporation - Common Stock trade on?
Liquidia Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Liquidia Corporation - Common Stock?
The ticker symbol for Liquidia Corporation - Common Stock is LQDA on the Nasdaq Stock Market
What is the current price of Liquidia Corporation - Common Stock?
The current price of Liquidia Corporation - Common Stock is 35.03
When was Liquidia Corporation - Common Stock last traded?
The last trade of Liquidia Corporation - Common Stock was at 03/27/26 04:00 PM ET
What is the market capitalization of Liquidia Corporation - Common Stock?
The market capitalization of Liquidia Corporation - Common Stock is 3.01B
How many shares of Liquidia Corporation - Common Stock are outstanding?
Liquidia Corporation - Common Stock has 3B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.